# Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects

> **NCT03159442** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 25 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease - COPD

## Interventions

- **DRUG:** AZD8871
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03159442
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-19
- **Primary completion:** 2017-10-13
- **Final completion:** 2017-10-13
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-10-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03159442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03159442, "Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03159442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*